1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Information Services
Vynleads, Inc.

Vynleads, Inc.

VYND
Vynleads, Inc.US flagOther OTC
0.41
USD
- -
- -
7.51MMarket Cap
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.24
0.16
0.03
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.04
-0.05
-0.03
-0.03
-0.02
-0.02
-0.02
-0.02
-0.01
-0.01
Free Cash Flow per Basic Share
-0.06
-0.02
- -
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.04
-0.09
-0.12
-0.15
-0.17
-0.19
-0.22
-0.22
-0.17
-0.17
Tangible Book Value per Share
0.04
- -
-0.01
-0.03
-0.04
-0.05
-0.07
-0.02
-0.02
-0.02
Basic Weighted Avg Shares
11
11
11
11
12
12
12
13
18
18
Sales/Revenue/Turnover
3
2
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-16.42
-28.47
-75.27
-767.25
-55,118.39
-533,159.18
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-16.09
-28.51
-76.4
-786.6
-56,111.78
-558,414.29
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
-1
-1
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
1
- -
- -
- -
- -
-1
-1
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
18
18
18
Market Capitalization
8
5
8

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
15.04%
55.01%
Free Cash Flow
- -
0.43%
-3.14%
Net Income, GAAP
- -
-6.93%
-2.35%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
-0.01
-0.01
- -
-0.02
2025
-0.01
- -
- -
- -
-0.01
2026
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Alex J. Mannine
Full Time Employees
1
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
596 Herrons Ferry Road Rock Hill SC United States of America 29730
IPO Date
Feb 24, 2020
CIK
0001745078
Website
vynleads.com
Similar Companies
Cegedim (ALCGM.PA)
Veeva Systems Inc. (VEEV)
Binovi Technologies Corp. (BNVIF)
EcoNaviSta, Inc. (5585.T)
Convey Health Solutions Holdings, Inc. (CNVY)
Craneware plc (CRWRF)
Business
Vynleads, Inc. (VYND) develops and provides health and wellness technology solutions focused on natural lifestyle interventions for chronic dietary-impacted diseases, primarily targeting prediabetic individuals and type 2 diabetes sufferers in the United States; its core offerings include the Done With Diabetes (DWD) program, an application delivering comprehensive member wellness support through community features, data-driven tools, and personalized strategies; the Lifestyle Blueprint, a digital guide with modules such as The Foundation, The Meal Plan, Diabetes Free Lifestyle, and Taking Control, accompanied by recipe books and dietary recommendations for a very low-calorie eight-week protocol; nutritional supplements including DWDx3 Advanced Daily Supplement and Premium-Grade Omegax3; and monthly subscriptions to proprietary newsletters covering healthy living topics, with all products distributed via online channels. The company operates in the health information services segment of the healthcare industry, emphasizing patient-centric care, preventative strategies, and technology-enabled scalability to support global health missions while complementing traditional medical therapies. Founded in 2015 and headquartered at 596 Herrons Ferry Road, Suite 301, Rock Hill, South Carolina, Vynleads maintains a lean team of one employee led by CEO Alex Mannine, with no reported major acquisitions, funding rounds, partnerships, new product launches, or strategic shifts in the last one to two years.